PYC Therapeutics LimitedASX: PYC

PKD Program - ASN Presentation

· Issued by PYC Therapeutics Limited via ASX

Filed with ASX · · 14 pages · English

Release

23 October 2026 POLYCYSTIC KIDNEY DISEASE PROGRAM – AMERICAN SOCIETY OF NEPHROLOGY PRESENTATION • PYC is a precision medicine company dedicated to changing the lives of patients with genetic diseases who have no treatment options available • The Company is progressing a drug candidate (known...

PYC Therapeutics Limited on 6ix

In the deck

Earlier from PYC Therapeutics

Later from PYC Therapeutics

All PYC Therapeutics news releases